News for Healthier Living

Caris Life Sciences Publishes Study Showing its Multi-Layer AI-Based Tissue of Origin Predictions are Best-in-Class and Identify when Patients have been Misdiagnosed

Caris Life Sciences(r) (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer, recently published a study on the development and validation of Caris' latest version of Caris GPSai(tm) in AACR's Cancer Research Communications Journal.

August 5, 2025


August 14 2025

August 13 2025

August 12 2025

August 11 2025

August 10 2025

August 9 2025

August 8 2025

August 7 2025

August 6 2025

August 5 2025

August 4 2025

August 3 2025

August 2 2025

August 1 2025